🇺🇸

Broad Market

· daily

US Material Events SEC 8-K Filings — October 23, 2026

Across the 50 filings for the Material Events Monitor stream (2026-10-23), the dominant theme is capital-structure and financing activity: convertible and committed-equity facilities (Expion360, Traws Pharma, Evernorth), a $2.5B senior notes refinancing (Workday), a $447M Conduent revolver extension, and a $3B Marvell revolver upsizing all reshape liquidity and dilution profiles. Management turnover is pervasive, with CFO or CAO departures and interim or replacement appointments at Premier Air Charter, Offerpad, LQR House, AB Commercial Real Estate Debt Fund, and Myers/Macy's/SiTime/Barnes & Noble board changes, though nearly all are stated as non-disagreement exits. M&A and disposition activity is active (Red Cat/Steyr Motors tender at EUR 39, 1-800-Flowers' $45M personalization sale, Unusual Machines closing DroneNX, Reliance Global's GPU cloud LOI, IPM's $2.7M AdTech deal). Distress signals concentrate in micro-caps: Lunai Bioworks is being voluntarily delisted with a $(9.0)M stockholders' deficit, BrooQLy is funding itself with 18% subordinated insider notes, and Edgemode is using OID-laden toxic-style promissory notes. Several filings lack quantitative period-over-period data, so trend synthesis is necessarily partial; the stream's enriched period comparisons are most usable for 1-800-Flowers (pro forma balance sheet) and Conduent (debt maturity extension).

50 high priority 50 total filings
· daily

Global High-Priority Regulatory Events — October 23, 2026

The 50-filing stream for 2026-10-23 is dominated by three clusters: (1) deal completions and delistings triggered by cash mergers, including Arcosa (cash at $150/share via CRH), Perfect Corp (USD 2.00 cash), and the NYSE/Nasdaq suspension notices for Global X and MUSQ ETFs; (2) listing-compliance distress among micro-caps (Dragonfly Energy, Lunai Bioworks, Akebia, Laser Photonics, STEM, Century Casinos, Polar Power), several of which are heading toward delisting or relying on dilutive financing; and (3) Indian corporate events, including Indian open offers (Charms Industries, Pasupati Fincap), CIRP-driven insolvency processes (VAS Infrastructure, Unitech, Reliance Communications, Arisinfra scheme), a major JSW Steel/JFE Sambalpur expansion, and a Sancode acquisition of Cirtek. Period-over-period data is strongest for 1-800-Flowers (divestiture cut FY26 revenue by roughly 9.7% while improving pro forma net loss and deleveraging term debt by about $21.65M), Newgen (Q2 FY27 revenue up roughly 18% YoY, with net profit rising to Rs 8,688 lakh from Rs 6,282 lakh QoQ), and Jupiter Life Line (total assets up to Rs 23,764M from Rs 21,603M). Target-side Indian deals show mixed trajectories: Bijnis turnover fell 14.1% despite a Rs 44 crore PAT on a Rs 7.8 crore net worth, and the Lloyds targets show turnover down 21.9% in FY26 in one filing versus a conflicting set of figures in the companion filing. Overall, cash-out M&A and forced delistings dominate the risk-reward, while micro-cap listing-deficiency notices are the most common negative signal.

50 high priority 50 total filings
· daily

US SEC Filings Daily Market Digest — October 23, 2026

Across 50 filings dated 2026-10-23, the dominant themes are 13F-driven institutional portfolio disclosures (roughly 15 filers, nearly all ETF-heavy with sole discretion and no prior-period comparisons, so no performance trend can be read from them), and a cluster of distressed or dilutive financing events among micro- and small-caps (Expion360, Circle8/Lyneer, Polar Power, Yimutian, Bio Green Med, Evernorth). Operating-company data is strongest at the large end: Steel Dynamics (Q3 net sales +34.8% YoY, net income +87.2%) and Teledyne (Q3 sales +9.4%, net income +23.0%) show healthy growth, though Teledyne's FX translation swing cut comprehensive income sharply. Weakness is concentrated in Five Point Holdings (Q3 net loss versus prior-year profit, nine-month operating cash flow of $(73.4)M), HiTek Global (net loss widened 50% YoY) and Hoops Scouting USA (net loss deepened to $(71.1)K). Insider activity is mostly routine compensation grants and director disposals to the issuer, with one notable buy (Nexus Capital at $3.55 in Rent the Runway). The most material single development is Circle8 Group's multi-party default cascade and the lender's threatened UCC Article 9 sale of Lyneer assets on or after October 27, 2026. Market implication for the day: near-term risk concentration sits in small-cap financing stress rather than in the broad large-cap complex, which the 13F filings show remains heavily ETF-weighted.

26 high priority 24 medium 50 total filings
· monthly

US Pre-Market SEC Filings Roundup — October 23, 2026

The overnight SEC stream for 2026-10-22 to 2026-10-23 is dominated by routine Form 4 director and officer equity awards and tax withholdings across Rivian, Lyft, CoreWeave and Fervo, which carry little market signal individually. The substantive developments are concentrated in a few areas: financial-sector results with mixed profiles (Flagstar's Q3 net income collapsed to $12M with provisions up $58M QoQ, while Primis posted higher Q3 earnings but missed its 1.00% ROAA target), a large acquisition-driven growth profile at Omnicom (Q3 revenue +59.1% YoY, but nine-month operating cash flow of only $37.8M against $3.2B of buybacks), and a distressed microcap cohort (Lunai Bioworks voluntary delisting after a $(9.0)M stockholders' deficit, Boxlight's S-1 registering 47.5M resale shares against 844,556 outstanding). SPAC activity is heavy, including the Quantum Space/Inflection Point S-4/A and 425 amendments, UY Scuti's trust-extension notes, and K&F Growth's extension proxy. Biotech/pharma news centered on Zymeworks' $55M-upfront Roche license for ZW209 and Zai Lab's mixed ESMO zoci data, with KT Corp disclosing a USD 386M counterclaim equal to about 2.63% of equity. Most remaining filings are cover-page or incorporation-by-reference documents whose substantive exhibits were not provided, so their materiality cannot be verified.

27 high priority 23 medium 50 total filings
· daily

US Material Events SEC 8-K Filings — October 22, 2026

Across the 50 SEC filings dated 2026-10-22, the dominant themes are officer and governance transitions, financing and capital-structure actions, and a handful of material M&A and earnings events. The most market-moving items are Meta's Q3 2026 results (revenue +26% YoY but a $9.89B legal charge compressing operating margin to 20% from 40%), H.B. Fuller's $850M notes issuance tied to the AMS acquisition, and Select Water's $900M notes tied to the Pilot Water acquisition, both carrying special mandatory redemption triggers. Earnings-based period comparisons are mixed: Deckers' record Q2 EPS (+27% YoY) was flattered by ~$0.28 of IEEPA tariff refunds while comparable DTC sales fell 6.4%, Lindsay's Q4 rebounded (+5% revenue, +39% operating income) but full-year revenue fell 6% to $635.9M, and Ategrity's record-low 84.7% combined ratio coexisted with a 35.7% decline in net income on investment losses. Distress and liquidity pressure appear in several names (America's Car-Mart's new $5.0M senior secured term loans, Glucotrack's reverse split to meet Nasdaq minimum bid, Shuttle Pharmaceuticals' auditor dismissal with going-concern history, and Nano Mobile's going-concern opinion), while the Invesco fund-family personnel changes (ten-plus trusts with an identical Gallegos-to-Anello PFAO transition) represent a single administrative event rather than separate signals.

50 high priority 50 total filings
· daily

Global High-Priority Regulatory Events — October 22, 2026

The 50-filing stream is dominated by distressed and restructuring events (Leslie's Chapter 11, Nasdaq delisting notices for SPACs and listed issuers, Indian CIRP/insolvency meetings) alongside a steady flow of M&A and open offers, mostly in India. Period-over-period data is mixed: Jindal Stainless standalone revenue rose 4.9% YoY and profit 22.0% YoY, but H1 PBT grew only ~3.8% and power/fuel costs rose ~25%, signalling margin pressure; Shakti Pumps' subsidiary turnover jumped on a low base; Oseaspre's losses widened YoY; ZLRAI turnover grew ~29%. The most market-moving items are the Leslie's bankruptcy (10/10 materiality, equity likely impaired), the Alaunos equity-compliance situation dependent on a Nasdaq Staff confirmation, and Globa Terra and Atlantic American facing imminent delisting proceedings. Positive strategic moves include the Data I/O V-TEK acquisition (~doubling revenue) and the Cadeler redomiciliation exchange offer, which remains short of its minimum condition. Several SPACs (Charlton Aria, Range Capital, DT Cloud Star, Texas Ventures III) are routinely extending deadlines via sponsor contributions, a sign of stalled combinations. Note that the 'Period' is a single day and several filings contain no quantitative data, which limits the depth of comparative analysis.

50 high priority 50 total filings
· daily

US SEC Filings Daily Market Digest — October 22, 2026

Across this 50-filing day, the dominant theme is divergence: strong top-line and earnings momentum at several large caps and regional banks (Element Solutions, CSX, IBM, Hexcel, Crown Castle's guidance raise, EastGroup, First Merchants, Eagle Bancorp) sits alongside credit and funding stress, going-concern-style listing pressure, and leverage strain at others (America's Car-Mart's fresh senior secured loans and covenant-driven amendments, Genenta's sub-$1 Nasdaq deficiency, Armour Residential's (12.9)% economic return and 8.24:1 leverage). Banks show a consistent pattern of sequentially improving margins and provisions alongside rising nonperforming assets and softer deposits (CNB Financial's deposits down $32.6M with NPAs at $56.9M, Beacon Financial's deposits down $303.3M and NPAs at $163.1M, Eagle's NPAs up $52.9M to $166.0M). Mortgage and housing-linked franchises are softening (First American flagged lower-for-longer origination; First Community's mortgage production fell 11.0% YoY), while commercial aerospace and industrial/infrastructure demand remain firm (Hexcel commercial aerospace +20.5%, CSX volume +5%). Capital return is active but selective: buybacks authorized at Beacon ($125M), Hexcel ($750M), EverQuote ($50M), and dividend increases at EastGroup (+12.9%) and First American (+11%). Watch items cluster around the November 4 earnings wave, the November 10 Alaunos Nasdaq panel hearing, and the November 25 Caesarstone AGM. Note that several filings (Acco Group, Alaunos) carry the largest financial-quality or listing-risk signals and deserve priority review despite their smaller or more technical footprints.

22 high priority 28 medium 50 total filings
· monthly

US Pre-Market SEC Filings Roundup — October 22, 2026

Across 50 overnight SEC filings for October 21-22, 2026, the dominant theme is divergence between headline earnings and underlying quality. Several regional banks and insurers posted sharp year-over-year net income gains driven by lower provisions, lapped securities losses, or tax items, while sequential momentum and deposit trends softened (Eagle Bancorp, CNB Financial, First Community, Enterprise Financial, First Bancorp). Industrials and tech showed the strongest operating momentum: CSX reported record Q3 revenue of $4.02B (+12% YoY) with operating income up 44%, IBM grew revenue 5% with Software +8%, and Element Solutions posted +52% reported sales (+13% organic) though Specialties organic growth was only 1% and cash fell about 64% YTD to $224.9M after roughly $866M of acquisitions. Real estate and REITs were mixed: EastGroup delivered 7.9% FFO growth and a 12.9% dividend increase, while Crown Castle's site rental revenue fell 5% on DISH termination impacts despite an AFFO-per-share increase of 11% and a raised Adjusted EBITDA outlook. Credit stress is visible in America's Car-Mart (new $5.0M senior secured term loan amid Specified Defaults), Alaunos (Nasdaq equity compliance contingent on a $350M private placement and Velaris merger), and Genenta (sub-$1 bid, compliance period to April 14, 2027). Mortgage-sensitive names flagged a lower-for-longer origination outlook, and ARMOUR Residential posted a Q3 economic return of (12.9)%. Insider activity was modest and largely routine sales under 10b5-1 plans at MediaAlpha and ASP Isotopes, with the Southport sponsor cancelling 666,667 Class B shares.

22 high priority 28 medium 50 total filings
· daily

US Material Events SEC 8-K Filings — October 21, 2026

Across 34 filings dated 2026-10-21 (22 new, 12 contextual), the dominant themes are capital-structure stress and transformative M&A rather than operating performance, since most filings disclose deal terms, governance changes, or financing rather than quantified period-over-period results. The most material event is Getty Images' prepackaged chapter 11 (materiality 10/10), which wipes out Class A equity and accelerates roughly $1.0 billion of debt, signaling distress among levered media/content names. Several small-cap and micro-cap issuers (Clean Energy Technologies, Securetech, Banzai, Soluna, Uinta/Integrated Rail) are relying on convertible, PIPE, or preferred structures with embedded dilution, a pattern that warrants caution. On the positive side, Group 1 Automotive's $1.08 billion Blue Sky acquisition and Smith & Wesson's accretive Savage Arms purchase (~7.9x adjusted EBITDA, ~$0.07 FY27 EPS accretion, 1.16x pro forma leverage) point to disciplined consolidation by cash-generative operators. Leadership succession is a recurring theme (Dell, OPAL Fuels, Voyager, MillerKnoll, Opendoor, Bank of America board adds), generally orderly. Quantitative period comparisons are sparse in this excerpt set, so conclusions lean on disclosed deal economics and balance-sheet signals rather than YoY trend data.

34 high priority 34 total filings
· daily

Global High-Priority Regulatory Events — October 21, 2026

The 48-filing stream for 2026-10-21 is dominated by Indian SEBI open offers and insolvency (CIRP) procedural notices, plus a cluster of US SEC corporate-control and distress events. The most market-significant developments are the Getty Images Chapter 11 prepackaged bankruptcy (equity cancelled with no recovery, ~$1.0B debt accelerated), Direct Digital Holdings' voluntary Nasdaq delisting after a suspension, the Holcim take-private tender for Cementos Pacasmayo at a 50%-owner premium structure, and the Smith & Wesson acquisition of Savage Arms at roughly 7.9x Adjusted EBITDA. Period-over-period data is sparse in the enriched fields; where present it is mixed, with Pine Labs' subsidiary SFNPL turnover down ~4.4% YoY, QeLearn down 37.6% over two years, Chirok Health recovering from a 2024 trough, and QeApps up ~46%. The M&A pipeline is active, with APEX/Korai ($3.5B pre-money), Group 1's $1.08B Blue Sky Hennessy dealership purchase, and Sagility/Chirok (up to $32.35M). Distress indicators cluster among Indian small caps under CIRP, GSM Stage 3 designations and fraud disclosures. Several filings are procedural or outside the stream's focus and are excluded.

48 high priority 48 total filings
· daily

US SEC Filings Daily Market Digest — October 21, 2026

The 2026-10-21 SEC filing batch is dominated by administrative and procedural disclosures, with a meaningful minority of material developments concentrated in SPAC/de-SPAC financing stress, dilution-prone capital raises, and a handful of strong quantitative prints. The most material quantitative results were Thermo Fisher's Q3 2026 (revenue $12.14B, up 9% YoY; adjusted operating margin up to 24.5% from 23.3%) and Elevance Health's Q3 2026 (operating revenue up 0.7% YoY, but operating gain flat and Health Benefits operating gain down 27.5%, offset by a raised FY2026 adjusted EPS floor of at least $29.00). Several small-cap and distressed names show clear financing pressure: Banzai's proxy seeks authority to dilute up to $14M at up to a 50% discount, Silicon Valley Acquisition Corp.'s subordinated notes are structurally junior to senior secured financing, and ClimateRock's shareholders' deficit reached $(10.46)M against only $5,370 of cash. Standard BioTools' S-4/A (materiality 9/10) for a reverse merger with Treeline, coupled with Casdin Capital's dual role as a ~23% LAB holder and Treeline investor, is the highest-stakes governance item in the batch. Adial Pharmaceuticals' 10-Q/A (materiality 9/10) shows a Q2 net loss of $51.99M, dominated by a $46.19M acquired IPR&D charge, with stockholders' equity swinging to a $(38.38)M deficit. Across the batch, the 13F filings (Luma, Farnam, Thayer, One River) describe concentrated large-cap holdings but provide no period-over-period comparisons, so portfolio-level trend analysis is not supportable from these documents.

15 high priority 35 medium 50 total filings
· monthly

US Pre-Market SEC Filings Roundup — October 21, 2026

Overnight SEC flow for 2026-10-20/21 was dominated by routine insider Form 4s, passive 13G/13D ownership updates, and foreign private issuer 6-Ks, with a handful of material developments. The clearest fundamental signal is Thermo Fisher's Q3 2026 beat (revenue $12.14B, up 9% YoY; adjusted EPS $6.68, up 15%; adjusted operating margin 24.5% vs 23.3%) against Elevance Health's mixed quarter (revenue up only 0.7% YoY, operating gain flat, Health Benefits operating gain down 27.5%, though FY EPS guidance was raised to at least $22.00 diluted and $29.00 adjusted). Distress and dilution risk concentrated in small caps: Banzai International's proxy seeks authority to nearly triple authorized shares and issue up to $14M at up to a 50% discount, Silicon Valley Acquisition Corp.'s EigenQ financing stacks subordinated paper beneath senior secured notes, ClimateRock reports roughly $8.2M of current liabilities against about $5K of unrestricted cash, and AITX's revenue growth (+5% YoY) is contingent on a largest-customer decline while it still reports a $2.68M quarterly operating loss. Insider activity was net-neutral to modestly negative, mostly Rule 10b5-1 sales and compensation awards at Zscaler and small-cap directors. Scheduled catalysts include Lufax Q3 results on October 27, the XWELL special meeting on October 28, and Jasper's November 13 special meeting, with Cadeler's exchange offer expiring today.

20 high priority 30 medium 50 total filings
· daily

US Material Events SEC 8-K Filings — October 20, 2026

Across the 50 filings for the Material Events Monitor (US SEC, 2026-10-20), the dominant theme is corporate control and capital structure activity rather than operating performance: large M&A (Dream Finders/Beazer at ~$2.2B EV, Maximus/Agile Defense at $660M, Silgan's MetalCo partnership, Myriad's $210M Prenatal sale to Labcorp), financing stress or restructuring (Onfolio's forbearance, Next Bridge's debt-for-revolver swap, Netcapital's delinquent filings and non-reliance disclosure, LanzaJet's senior secured notes), and a steady flow of board and executive succession. Period-over-period data is sparse in this batch, but where present it is mixed: Neptune Insurance grew revenue 34.3% YoY and net income 49.9% in Q3, yet its twelve-month net income margin fell 7.6pp to 22.7% with share-based compensation rising from $0.1M to $7.0M. Several filings are structurally bearish on balance-sheet quality (Onfolio, Netcapital, Next Bridge, AlTi's new $85M facility), while acquirers and bolt-on deals are generally framed positively. Insider and related-party activity is notable (Pluri's chairman-controlled purchase, Treasure Global's Malaysian insider placement, PURE Bioscience's director-led $555K raise, ESG Inc.'s change-of-control pending). Governance-driven board refreshes dominate the neutral-to-positive tail, with Insmed, Northern Trust, Whirlpool, and Apollo adding seasoned directors. Forward catalysts cluster in late October through early 2027, including Oro/Hertz, Onfolio's October 31 payment, Clearfield's November 10 results, Myriad's November 4 call, and Dorchester's October 30 closing.

50 high priority 50 total filings
· daily

Global High-Priority Regulatory Events — October 20, 2026

The 36 filings for the 2026-10-20 window are dominated by corporate-control and capital-structure events rather than classic bankruptcy or fraud: a large cash take-private-style consolidation in homebuilding (Dream Finders completing its roughly $2.2B all-cash acquisition of Beazer Homes, with Beazer delisted), a live contested tender for SoundThinking (Transom's $8.00 cash plus up to $3.00 CVR), and a sizeable cluster of SPAC extension and redemption votes and deadline pressures. Listing-compliance stress is concentrated in small caps (Lottery.com/SEGG facing suspension on October 23, SHF Holdings and XWELL bid-price deficiencies, and a run of Nasdaq 25-NSE delistings across Themes ETF Trust leveraged products). Closed-end fund and BDC issuer tender offers were broadly undersubscribed or prorated, with KREST tendering only about 73% of its cap and Herzfeld oversubscribed roughly 14x, signalling uneven shareholder liquidity demand across the sector. Period-over-period enriched fields are sparse in this set; the clearest quantitative trends are Beazer's pro forma revenue dip (about $39.03M to $38.97M) and net loss widening, and the Dream Finders leverage rise it has pre-announced. The most material implication for investors is event-driven: the SoundThinking and Beazer/Dream Finders outcomes, the Lottery.com suspension timeline, and the SPAC deadline cluster in November 2026 through January 2027.

36 high priority 36 total filings
· daily

US SEC Filings Daily Market Digest — October 20, 2026

The October 20, 2026 SEC filing stream is dominated by administrative 6-K and 425/S-series filings with little quantitative content, but several material developments stand out: Kimberly-Clark's $4.9B note offering to fund the Kenvue acquisition, Silgan's ~$9B-scale MetalCo partnership with a Trivium Packaging put option, Peoples Bancorp's pending acquisitions of Citizens National and Capital Bancorp, and Rapport Therapeutics' marginal Phase 2 mania readout. Earnings-based filings show a bifurcated picture: Northrop Grumman and Fabrinet posted solid top-line and net income growth (Fabrinet revenue +35.7% YoY to $4.64B, net income +42.3%) yet saw gross margin pressure, while Synchrony Financial net earnings fell 17% YoY to $892M with ROE down 410 bps and CET1 down to 12.9%. Pacific Airport Group revenue rose 21.8% YoY in 3Q26 but Montego Bay aeronautical revenue fell 28.2%, signaling uneven airport traffic. Smaller-cap and SPAC-related names carry the most dilution and financing risk (AITX, BioAtla, NuCube, Sonic Holdco, Healthy Choice/Host Digital, Copley Acquisition), and Equinor's ongoing buyback continues at rising prices. Overall the day's theme is capital-structure activity and deal execution rather than broad earnings momentum.

10 high priority 40 medium 50 total filings
· monthly

US Pre-Market SEC Filings Roundup — October 20, 2026

The overnight US SEC filing set for 2026-10-19 to 2026-10-20 is dominated by corporate-governance and capital-markets activity rather than broad operating results. Insider sales and beneficial-ownership exits cluster in small caps and de-SPAC names, with Cable One's Graham-affiliated exit at steeply declining prices (about $13.02 to $6.07 in six sessions) the most notable negative signal. Several large financing and M&A events stand out: Kimberly-Clark's $4.9 billion notes offering tied to the Kenvue deal, Peoples Bancorp's two pending bank acquisitions, and Northrop Grumman's raised 2026 guidance alongside slipping segment margins. Earnings-quality tension recurs: Synchrony Financial's Q3 net earnings fell 17% YoY despite record purchase volume, and Pacific Airport Group's 3Q26 revenue jumped 21.8% YoY while aeronautical revenue grew only 2.6%. Many 6-K filings (TC Energy, POET, Innate, ING, ZTO and others) are cover-only exhibit submissions whose substance could not be verified from the provided text. Watch items cluster around Kimberly-Clark's note closing (October 29), the Copley extension vote (October 29), the ATII/Forge Nano post-merger governance, and the Woori and POSCO earnings calls.

13 high priority 37 medium 50 total filings
· daily

US Material Events SEC 8-K Filings — October 19, 2026

Across 50 SEC filings dated October 19, 2026, the dominant theme is capital structure activity: refinancings (Integra, Enerpac, Chefs' Warehouse, Vail, FrontView), equity raises and dilutive private placements (Curis, OS Therapies, Glucotrack, Dogwood, Agassi Sports), and large M&A (Tradeweb-Trumid at ~$1.97B, Centrus-Westerman at ~$116M, TCGX-TriGemX SPAC at ~$246M gross proceeds). Governance churn is widespread, with CFO transitions at Torrid, JELD-WEN, Lear, CRISPR, and CarMax, plus board resignations at Polomar, Apogee, Omnitek, and Professional Diversity Network. Quantitative period-over-period data is sparse: only Rocky Mountain Chocolate Factory provides a full YoY/QoQ set, showing revenue down ~2.5% YoY, a six-month net loss nearly tripling to $2.4M, cash falling to $416K, and current liabilities at $13.6M. Chord Energy is the main positive operating datapoint, with volumes above guidance and $205MM of 3Q26 buybacks. Distress is concentrated in Cambium Networks' UK insolvency sale, Apogee's restatement, and micro-cap financing stress. Market-implication weight rests on Tradeweb, Rocky Mountain Chocolate's strategic review, and ZoomInfo's $44M settlement.

50 high priority 50 total filings
· daily

Global High-Priority Regulatory Events — October 19, 2026

Across the 50 filings for the Global High Priority Market Events stream (period 2026-10-19), the dominant themes are distressed situations and corporate control transactions. Insolvency and delisting events cluster heavily: Dharan Infra-EPC's CIRP continues after NCLT rejected a creditor settlement-based withdrawal, Sun Granite is extending its resolution expression-of-interest window, Cambium Networks' UK unit is being sold out of administration, and Stardust Power faces accelerated Nasdaq delisting with its CFO departing. Several US delistings (Atkore post-Prysmian merger, Voya EM High Dividend fund, Algoma warrants) reflect completed reorganizations rather than distress. Control and restructuring activity is elevated: mandatory and voluntary open offers (Kuber Udyog, RR Metalmakers, Genomic Valley, Inani Securities, Oxford Industries), the PFC-REC merger clearing exchange observation letters, the Eaton/Dana Mobility combination, and SPAC business combinations (TCGX). Period-over-period data is thin in the enriched fields, but the few quantified results are weak: Rocky Mountain Chocolate's current liabilities nearly doubled and cash fell to $416K, while Scienture's Q3 revenue rose 256% QoQ from a small base. Management and sponsor activity points to balance-sheet stress in micro-cap issuers and pending-regulatory-approval risk in large mergers.

50 high priority 50 total filings
· daily

US SEC Filings Daily Market Digest — October 19, 2026

The October 19, 2026 digest covers a broad mix of 50 SEC filings dominated by foreign private issuer 6-K press-release wrappers whose substance sits in unseen exhibits, alongside 13F and 13G ownership disclosures, Form 4 insider transactions, proxy materials, and a handful of material corporate events. The most market-moving items are the Synaptics all-cash $123.00 per-share merger with onsemi (valued at a 22% premium, 10/10 materiality, with a competing Party A stock-based proposal creating valuation tension), Fifth Third Bancorp's Q3 2026 print (adjusted EPS $1.13 versus reported $0.90, with net interest income up 49% YoY on the Comerica acquisition but noninterest expense up 62% YoY), and Atlantic American's FY2025 10-K/A showing revenue up 11.9% to $210.4M and net income swinging to $6.0M from a $1.4M loss. Governance and restatement risk is elevated in the SPAC cluster: Apogee Acquisition Corp disclosed Q2 2026 restatement affecting trust contributions and redeemable share classification, with a director and COO departing, while Archimedes Tech SPAC II shareholders approved the Forge Nano combination but with notable dissent (about 2.07M AGAINST on charter proposals). Insider activity was light and mostly routine (director RSU and share awards at Flex, Tencent Music and Tesla-adjacent boards), with the open-market buys at Elite Pharmaceuticals ($26K at $0.26) and FingerMotion (CEO and CFO small purchases) the only clear conviction signals. Quarterly period-over-period comparisons were absent for most 13F and 6-K filings, so portfolio-level margin and growth trends are only assessable for the bank and insurer filings.

22 high priority 28 medium 50 total filings
· monthly

US Pre-Market SEC Filings Roundup — October 19, 2026

Across the 50 overnight SEC filings for 2026-10-18 to 2026-10-19, the dominant themes are corporate-control and transaction events (Synaptics/onsemi all-cash merger at $123.00/share, Perfect Corp merger approval, Archimedes/Forge Nano business combination approval, Blocksight acquisition by OpenWorld/VerifyMe), and a cluster of SPAC governance stress (Apogee restatement and director/officer exits, Starry Sea meeting postponement with ~3.9M shares tendered for redemption). Large-cap financial results were the most quantitatively rich disclosure: Fifth Third reported Q3 2026 EPS of $0.90 (adjusted $1.13) with NII up 49% YoY on the Comerica acquisition but noninterest expense up 62% YoY, and Atlantic American reported FY2025 revenue of $210.4M (+11.9%) with net income swinging to $6.0M from a $1.4M loss. Insider activity was light and mostly routine (director RSU/share awards at Flex, Tencent Music and Fifth-style grants), with open-market buying at micro-caps (Elite Pharmaceuticals director buying 100,000 shares at $0.26; FingerMotion CEO and CFO each buying small lots at ~$0.17-$0.18) and one 10b5-1 sale at Sea Ltd. Several filings (Transocean's ~$550M of new drillship backlog, Tesla's proxy and governance items, BBVA buyback progress at ~7.9% of tranche) carried clear operating or capital-return signals, while many 6-K/press-release-only filings lacked the content needed for analysis. Market implication: event-driven M&A and SPAC liquidation dynamics are likely to drive the most immediate price action, while financial-sector results and micro-cap insider buys offer secondary read-throughs.

22 high priority 28 medium 50 total filings